ROHIT KAPOOR, M.D.
Hematology & Oncology Physician · LIVE OAK, TX
Individual Active NPI 1750392908
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 688 | 90,665 | $7,456,845 | $2,591,898 | $2,065,678 |
| 2023 | 660 | 121,004 | $9,636,025 | $2,795,466 | $2,227,675 |
| 2022 | 715 | 105,129 | $9,614,341 | $2,615,990 | $2,084,221 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 20,400 | $56 | $45 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 6,610 | $0 | $0 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 4,150 | $0 | $0 |
| 36415 | Insertion of needle into vein for collection of blood sample | 2,526 | $9 | $9 |
| 85027 | Complete blood cell count (red cells, white blood cell, platelets), automated test | 2,447 | $6 | $6 |
| 99213 | Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 1,284 | $84 | $62 |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 1,092 | $25 | $20 |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 1,068 | $16 | $12 |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 697 | $3 | $3 |
| 99214 | Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 604 | $116 | $91 |
| J1750 | Injection, iron dextran, 50 mg | 593 | $16 | $13 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 555 | $74 | $59 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | J5369 | TX |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Texas
- NPI 1447208384
- NPI 1629237912
- NPI 1245425503
- NPI 1790805877
- NPI 1225383680
- NPI 1184246142
- NPI 1841603636
- NPI 1679578926
See all Hematology & Oncology Physician providers in Texas →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.